Our Mission: Improving and Extending the Lives of Patients with Cancer
 
 
 

Business Development

For information regarding licensing or research collaboration opportunities with Celator, contact:

Scott Jackson, R.Ph., M.B.A.
Chief Executive Officer

Celator Pharmaceuticals, Inc.
303B College Road East
Princeton, NJ 08540
Telephone: (609) 243-0123
info@celatorpharma.com

 

 

 


Celator is pioneering a new approach to combination chemotherapy based on synergistic drug ratios.

 

 

 

 
© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.